Abstract
HIV-1 infection is unique with regard to immune responses, in which there is evidence for immune paradox, i. e., both immune activation and immune suppression. Immune stimulation is evident by elevated levels of various cytokines and hyperimmunoglobulinemia, whereas immune suppression is associated with quantitative and qualitative deficiency of T cells, especially of CD4+ T cells (reviewed in Fauci, 1988). It appears that HIV-1 or its envelope glycoproteins (gp160, gp120) can induce these paradoxical changes by various mechanisms, including blocking CD4-major histocompatibility complex (MHC) class II interaction and by altering signal transduction pathway. In this chapter, I will review the role of HIV-1 and its glycoproteins in activation and downregulation of signaling pathways in human T cells.
Keywords
- Human Immunodeficiency Virus
- Human Immunodeficiency Virus Type
- Tyrosine Phosphorylation
- Protein Tyrosine Kinase
- Envelope Glycoprotein
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Banda, N. K., Bernier, J., Kurahara, D. K., Kurrle, R., Haigwood, N., Sekaly, R.-P, and Finkel, T. H., 1992, Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis, J. Exp. hied. 176:1099–1106.
Cayota, A. E., Vuiller, R., Siliciano, J., and Dighiero, G., 1994, Defective protein tyrosine phosphorylation and altered levels of p59fyn and p56lck in CD4 T cells from HIV-1-infected patients, Int. Immunol 6:611–621.
Cefai, D., Debre, P., Kaczorek, M., Idziorek, T., Autran, B., and Bismuth, G., 1990, Human immunodeficiency virus 1 glycoprotein gp120 and gp160 specifically inhibit the CD3/T cell antigen receptor phosphoinositol pathway, J. Clin. Invest. 86:2117–2124.
Cefai, D., Ferrer, M., Serpente, N., Idziorek, T., Dautry-Varsat, A., Debre, P., and Bismuth, G., 1992, Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 p56lck, J. Immunol. 149:285–294.
Chirmule, N., Kalyanaraman, V., Oyaizu, N., and Pahwa, S., 1988, Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses, J. AIDS 1:425–430.
Chirmule, N., Kalyanaraman, V. S., Oyaizu, N., Slade, H. B., and Pahwa, S., 1990, Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein 120 of human immunodeficiency virus, Blood 75:152–159.
Chirmule, N., Kalyanaraman, V. S., and Pahwa, S., 1994, Signal transduced through the CD4 molecule on T lymphocytes activate NF-kB, Biochem. Biophys. Res. Commun. 203:498–505.
Chirmule, N., Goonewardena, H., Pahwa, S., Pasieka, R., Kalyanaraman, V. S., and Pahwa, S., 1995, HIV-1 envelope glycoproteins induce activation of activated protein-1 in CD4+ T cells, J. Biol. Chem. 270:19364–19369.
Cohen, D. I., Tani, Y., Tian, H., Boone, E., Samelson, L. E., and Lane, H. C., 1992, Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1, Science 256:542–545.
Corado, J., Mazerolles, F., LeDeist, F., Barbat, C., Kaczorek, M., and Fischer, A., 1991, Inhibition of CD4+ T cell activation and adhesion by peptides derived from the gp160, J. Immunol. 147:475–482.
Diamond, D. C., Sleckman, B. P., Gregory, T., Lasky, L. A., Greenstein, J. L., and Burakoff, S. J., 1988, Inhibition of CD(+) T cell function by the HIV envelope protein gp120, J. Immunol 141:3715–3717.
Fauci, A. S., 1988, The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis, Science 239:617–623.
Fields, A. P., Bednarik, D. P., Hess, A., and May, W. S., 1988, Human immunodeficiency virus induces phosphorylation of its cell surface receptor, Nature 333:278–280.
Gaulton, G. N., Brass, L. F., Kozbor, D., Pletcher, C. H., and Hoxie, J. A., 1992, Inhibition of T cell antigen receptor-dependent phosphorylation of CD4 in human immunodeficiency virus type 1 infected cells, J. Biol. Chem. 267:4102–4109.
Goldman, F., Jensen, W. A., Johnson, G. L., Heasley, L., and Cambier, J. C., 1994, gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation, J. Immunol. 153:2905–2917.
Gupta, S., 1993, Signal transduction defect in the acquired immunodeficiency syndrome and AIDS-related complex, Thymus 22:83–90.
Gupta, S., and Vayuvegula, B., 1987, Human immunodeficiency virus-associated changes in signal transduction, J. Clin. Immunol. 7:486–489.
Gupta, S., Aggarwal, S., Kim, C., and Gollapudi, S., 1994, Human immunodeficiency virus-1 gp120 induces changes in protein kinase C isozymes—A preliminary report, Int. J. Immunopharmacol. 16:197–204.
Hivroz, C., Mazerolles, F., Soula, M., Fagard, R., Graton, S., Meloche, S., Sekaly, R.-R, and Fischer, A., 1993, Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes, Eur. J. Immunol. 23:600–607.
Horak, I. D., Popovic, M., Horak, E. M., Lucas, P. J., Gress, R. E., June, C. H., and Bolen, J. B., 1990, No T-cell tyrosine protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120, Nature 348:557–560.
Houlgatte, R., Scarmato, P., Marhomy, S. E., Martin, M., Ostankovitch, M., Lafosse, S., Vervisch, A., Auffray, C., and Tonneau, D. P., 1994, MHC class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4, J. Immunol. 152:4475–4488.
Hoxie, J. A., Rackowski, J. L., Haggarty, B. S., and Gaulton, G. N., 1988, T4 endocytosis and phosphorylation induced by phorbol esters but not not by mitogen or HIV infection, J. Immunol. 140:786–795.
Jabado, N., LeDeist, F., Fischer, A., and Hivroz, C., 1994, Interaction of HIV gp120 and anti-CD4 antibodies with CD4 molecule on human CD4+ T cells inhibits the binding activity of NFAT, NF-kB and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity, Eur. J. Immunol. 24:2646–2652.
June, C. H., Bluestone, J. A., Nadler, L. M., and Thompson, C. B., 1994, The B7 and CD28 receptor families, Immunol. Today 15:321–331.
Juszczak, R. J., Turchin, J., Truneh, A., Culp, J., and Kassis, S., 1991, Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with the CD4 on human T lymphocytes, J. Biol. Chem. 266:11176–11183.
Kaufmann, R., Laroche, D., Buchner, K., Hucho, F., Rudd, C., Lindschau, P., Ludwig, A., Hoer, E., Oberdisse, E., Kopp, J., Körner, I. J., and Repke, H., 1992, The HIV-1 surface protein gp120 has no effect on transmembrane signal transduction, J. AIDS 15:760–770.
Kornfeld, H., Cruickshank, W. W., Pyle, S., Berman, J. S., and Center, D. M., 1988, Lymphocyte activation by HIV-1 envelope glycoprotein, Nature 335:445–454.
Linette, G. P., Hartzman, R. J., Ledbetter, J. A., and June, C. H., 1988, HIV-1 infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor, Science 241:573–576.
Weiss, A., and Littman, D. R., 1994, Signal transduction by lymphocyte antigen receptors, Cell 76:263–274.
Mann, D., Lasane, F., Popovic, M., Arthur, L. O., Robe, G. W., Blattner, W. A., and Newman, M. J., 1987, HTLV III large envelope glycoprotein (gp120) suppresses PHA-induced lymphocyte blastogenesis, J. Immunol. 138:2640–2644.
Mittler, R. S., and Hoffman, M. K., 1988, Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation, Science 245:1380–1382.
Neudorf, S. M. L., Jones, M. M., McCarthy, B. M., Harmony, J. A. K., and Choi, E. M., 1990, The CD4 molecule transmits biochemical information important in the regulation of T lymphocyte activity. Cell Immunol. 125:301–314.
Nye, K. E., and Pinching, A. J., 1990, HIV infection of H9 lymphoblastoid cells chronically activates the inositol polyphosphate pathway, AIDS 4:41–45.
Nye, K. E., Riley, G. A., and Pinching, A. J., 1992, The defect seen in the PI hydrolysis pathway in HIV infected lymphocytes and lymphoblastoid cells is due to inhibition of the 1,4,5 triphosphate, 1,3,4,5 tetrakisphosphate and 5-phosphomonoesterase, Clin. Exp. Immunol. 89:89–93.
Orloff, G. M., Kennedy, M. S., Dawson, C., and McDougal, J. S., 1991, HIV-1 binding to CD4 T cells does not induce a Ca++ influx or lead to activation of protein kinases, AIDS Res. Hum. Retrovir. 7:587–593.
Oyaizu, N., Chirmule, N., Kalyanaraman, V S., Hall, W. W., Good, R. A., and Pahwa, S., 1990, Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA, Proc. Natl. Acad. Sci. USA 87:2379–2383.
Prasad, K. V. S., Kapeller, R., Janssen, O., Duke-Cohan, J. S., Cantley, L. C., and Rudd, C. E., 1993, Phosphatidylinositol (PI) 3-kinase binding to the CD4-p56lck complex: The p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase, Mol. Cell. Biol. 13:7708–7717.
Rudd, C. E., Janssen, O., Cai, Y.-C., de Silva, A. J., Raab, M., and Prasad, K. V. S., 1994, Two step TCRζ/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine and lipid kinases, Immunol. Today 15:225–234.
Ryu, S. E., Kwong, P. D., Truneh, A., Porter, T. G., Arthos, J., Rosenberg, M., Dai, X., Xuong, N. H., Axel, R., Sweet, R. W., and Hendrickson, W. A., 1990, Crystal structure of an HIV-binding recombinant fragment of human CD4, Nature 348:419–426.
Selvey, L. A., Morse, H. C., III, June, C. H., and Hodes, R. J., 1995, Analysis of antigen receptor signaling in B cells from mice with retrovirus-induced acquired immunodeficiency syndrome, J. Immunol. 154:171–179.
Shalaby, M. R., Krowka, J. R., Gregory, T. J., Hirabayashi, S. E., McCabe, S. M., Kaufman, D. S., Stites, D. P., and Ammann, A. J., 1987, The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro, Cell Immunol. 110:140–148.
Shin, J., Doyle, C., Yang, Z., Kappes, D., Strominger, J. L., 1990, Structural features of the cytoplasmic region of CD4 required for internalization, EMBO J. 9:425–434.
Soula, M., Fagard, R., and Fischer, S., 1992, Interaction of human immunodeficiency virus glycoprotein 160 with CD4 in Jurkat cells increases p56lck autophosphorylation and kinase activity, Int. Immunol. 4:295–299.
Wang, J., Yan, Y., Garrett, T. R J., Liu, J., Rogers, D. W., Garlick, R. L., Tarr, G. E., Husain, Y., Reinherz, E. L., and Harrison, S. C., 1990, Atomic structure of a fragment of human CD4 containing two immunoglobulin-like-domains, Nature 348:411–418.
Weinhold, K. J., Lyerly, H. K., Stanley, H. D., Austin, A. A., Matthews, T. J., and Bolognesi, D. P., 1989, HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection, J. Immunol 142:3091–3097.
Yoshida, H., Kaga, K., Moroi, Y., Kimura, G., and Momoto, K., 1992, The effect of p56lck, a lymphocyte-specific protein tyrosine kinase on syncytium formation by HIV envelope glycoprotein, Int. Immunol. 4:233–242.
Zauli, G., Furlini, G., Vitale, M., Re, M. C., Gibellini, D., Zamai, L., and Visani, G., 1994, CD4 engagement by HIV-1 in TF-1 hematopoietic progenitor cells increases protein kinase C activity and reduces intracellular Ca++ levels, Microbiologica 17:85–92.
Zorn, N. E., Weill, C. L., and Russell, D. H., 1990, The HIV protein GP120 activates nuclear protein kinase C in nuclei from lymphocytes and brain. Biochem. Biophys. Res. Commun. 166:1133–1139.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gupta, S. (1996). Effects of HIV-1 and HIV-1 Envelope Glycoproteins on Signaling Pathways in Human T Lymphocytes. In: Gupta, S. (eds) Immunology of HIV Infection. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0191-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0191-0_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0193-4
Online ISBN: 978-1-4899-0191-0
eBook Packages: Springer Book Archive